ImmuCell CorporationICCCNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank97
5Y CAGR+118.7%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+118.7%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
50.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 42.72% |
| Q3 2025 | -0.39% |
| Q2 2025 | 2.43% |
| Q1 2025 | 4.83% |
| Q4 2024 | -4.80% |
| Q3 2024 | 7.72% |
| Q2 2024 | -5.51% |
| Q1 2024 | -1.44% |
| Q4 2023 | -3.96% |
| Q3 2023 | -4.16% |
| Q2 2023 | -3.99% |
| Q1 2023 | -6.94% |
| Q4 2022 | -5.01% |
| Q3 2022 | -4.24% |
| Q2 2022 | 0.02% |
| Q1 2022 | 1.34% |
| Q4 2021 | 1.45% |
| Q3 2021 | -0.48% |
| Q2 2021 | 9.14% |
| Q1 2021 | -1.46% |
| Q4 2020 | 0.85% |
| Q3 2020 | -4.37% |
| Q2 2020 | 1.07% |
| Q1 2020 | -25.03% |
| Q4 2019 | 31.85% |
| Q3 2019 | -4.43% |
| Q2 2019 | -20.89% |
| Q1 2019 | 36.06% |
| Q4 2018 | -4.40% |
| Q3 2018 | -3.55% |
| Q2 2018 | -0.05% |
| Q1 2018 | -8.99% |
| Q4 2017 | 9.03% |
| Q3 2017 | 3.76% |
| Q2 2017 | -0.86% |
| Q1 2017 | 0.29% |
| Q4 2016 | 6.80% |
| Q3 2016 | 0.53% |
| Q2 2016 | -8.37% |
| Q1 2016 | 53.79% |